Lanzira 15 mg Orally Disintegrating Tablet is used in the treatment of gastro-oesophageal reflux disease, erosive esophagitis, and Zollinger Ellison syndrome

Medicinal Benefits:

Lanzira 15 mg Orally Disintegrating Tablet belongs to a group of antiulcer medicines called 'proton pump inhibitors' indicated in the treatment of gastroesophageal reflux disease, erosive esophagitis, and Zollinger Ellison syndrome. It is also used to prevent and treat ulcers of the oesophagus. Lanzira 15 mg Orally Disintegrating Tablet contains 'Lansoprazole' that works by blocking the action of an enzyme known as the gastric proton pump responsible for the production of acid. This helps in reducing the symptoms of heartburn, reflux and promotes the healing of ulcers.

FAQs

How does Lanzira 15 mg Orally Disintegrating Tablet work?

Lanzira 15 mg Orally Disintegrating Tablet works by blocking the action of an enzyme known as the gastric proton pump responsible for the production of acid. This helps in reducing the symptoms of heartburn, reflux and promotes the healing of ulcers

Does Lanzira 15 mg Orally Disintegrating Tablet cause itchiness?

Lanzira 15 mg Orally Disintegrating Tablet may cause swelling and itchiness of the fingers and toes. Try applying an anti-itch cream or a moisturising cream. If the condition persists after two weeks, consult your doctor.

Can I give indigestion medicines along with Lanzira 15 mg Orally Disintegrating Tablet to my child?

You are advised to maintain a gap of two hours between Lanzira 15 mg Orally Disintegrating Tablet and indigestion medicines. However, please consult a doctor before giving indigestion/antacid medicines along with Lanzira 15 mg Orally Disintegrating Tablet to the child.